188 related articles for article (PubMed ID: 28495524)
41. Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis.
Rarok AA; Stegeman CA; Limburg PC; Kallenberg CG
J Am Soc Nephrol; 2002 Sep; 13(9):2232-8. PubMed ID: 12191967
[TBL] [Abstract][Full Text] [Related]
42. Remote Activation of a Latent Epitope in an Autoantigen Decoded With Simulated B-Factors.
Pang YP; Casal Moura M; Thompson GE; Nelson DR; Hummel AM; Jenne DE; Emerling D; Volkmuth W; Robinson WH; Specks U
Front Immunol; 2019; 10():2467. PubMed ID: 31708920
[TBL] [Abstract][Full Text] [Related]
43. Perspectives: modelling the vasculitis and granulomatous tissue destruction of granulomatosis with polyangiitis (GPA).
Gadola SD
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S1-2. PubMed ID: 22640646
[No Abstract] [Full Text] [Related]
44. A hydrophobic patch on proteinase 3, the target of autoantibodies in Wegener granulomatosis, mediates membrane binding via NB1 receptors.
Korkmaz B; Kuhl A; Bayat B; Santoso S; Jenne DE
J Biol Chem; 2008 Dec; 283(51):35976-82. PubMed ID: 18854317
[TBL] [Abstract][Full Text] [Related]
45. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.
Hu N; Westra J; Huitema MG; Bijl M; Brouwer E; Stegeman CA; Heeringa P; Limburg PC; Kallenberg CG
Arthritis Rheum; 2009 May; 60(5):1548-57. PubMed ID: 19404956
[TBL] [Abstract][Full Text] [Related]
46. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
[TBL] [Abstract][Full Text] [Related]
47. Interaction of proteinase 3 with its associated partners: implications in the pathogenesis of Wegener's granulomatosis.
Witko-Sarsat V; Reuter N; Mouthon L
Curr Opin Rheumatol; 2010 Jan; 22(1):1-7. PubMed ID: 19881350
[TBL] [Abstract][Full Text] [Related]
48. 18F-FDG PET/CT findings preceded elevation of serum proteinase 3 antineutrophil cytoplasmic antibodies in Wegener granulomatosis.
Ito K; Minamimoto R; Yamashita H; Morooka M; Okasaki M; Mimori A; Kubota K
Clin Nucl Med; 2014 Jan; 39(1):e67-8. PubMed ID: 23579980
[TBL] [Abstract][Full Text] [Related]
49. Clinical association of mixed connective tissue disease and granulomatosis with polyangiitis: a case report and systematic screening of anti-U1RNP and anti-PR3 auto-antibody double positivity in ten European hospitals.
Tubery A; Fortenfant F; Combe B; Abreu I; Bossuyt X; Chretien P; Desplat-Jégo S; Fabien N; Hue S; Johanet C; Lakomy D; Vincent T; Daïen CI
Immunol Res; 2016 Dec; 64(5-6):1243-1246. PubMed ID: 27618831
[TBL] [Abstract][Full Text] [Related]
50. Anti-PR3 immune responses induce segmental and necrotizing glomerulonephritis.
Primo VC; Marusic S; Franklin CC; Goldmann WH; Achaval CG; Smith RN; Arnaout MA; Nikolic B
Clin Exp Immunol; 2010 Mar; 159(3):327-37. PubMed ID: 20015271
[TBL] [Abstract][Full Text] [Related]
51. Skewed Fc glycosylation profiles of anti-proteinase 3 immunoglobulin G1 autoantibodies from granulomatosis with polyangiitis patients show low levels of bisection, galactosylation, and sialylation.
Wuhrer M; Stavenhagen K; Koeleman CA; Selman MH; Harper L; Jacobs BC; Savage CO; Jefferis R; Deelder AM; Morgan M
J Proteome Res; 2015 Apr; 14(4):1657-65. PubMed ID: 25761865
[TBL] [Abstract][Full Text] [Related]
52. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases.
Korkmaz B; Jenne DE; Gauthier F
Int Immunopharmacol; 2013 Dec; 17(4):1198-205. PubMed ID: 23886601
[TBL] [Abstract][Full Text] [Related]
53. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Ozaki S
Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
[TBL] [Abstract][Full Text] [Related]
54. Expression profile of proinflammatory genes in neutrophil-enriched granulocytes stimulated with native anti-PR3 autoantibodies.
Surmiak M; Kaczor M; Sanak M
J Physiol Pharmacol; 2012 Jun; 63(3):249-56. PubMed ID: 22791638
[TBL] [Abstract][Full Text] [Related]
55. Cutaneous manifestations of pediatric granulomatosis with polyangiitis: a clinicopathologic and immunopathologic analysis.
Wright AC; Gibson LE; Davis DM
J Am Acad Dermatol; 2015 May; 72(5):859-67. PubMed ID: 25748311
[TBL] [Abstract][Full Text] [Related]
56. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
Lally L; Spiera R
Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
[TBL] [Abstract][Full Text] [Related]
57. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM
Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394
[TBL] [Abstract][Full Text] [Related]
58. There is no benefit in routinely monitoring ANCA titres in patients with granulomatosis with polyangiitis.
Verstockt B; Bossuyt X; Vanderschueren S; Blockmans D
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-72-6. PubMed ID: 26016753
[TBL] [Abstract][Full Text] [Related]
59. A critical evaluation of commercial immunoassays for antineutrophil cytoplasmic antibodies directed against proteinase 3 and myeloperoxidase in Wegener's granulomatosis and microscopic polyangiitis.
Csernok E; Ahlquist D; Ullrich S; Gross WL
Rheumatology (Oxford); 2002 Nov; 41(11):1313-7. PubMed ID: 12422006
[TBL] [Abstract][Full Text] [Related]
60. Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's).
Espy C; Morelle W; Kavian N; Grange P; Goulvestre C; Viallon V; Chéreau C; Pagnoux C; Michalski JC; Guillevin L; Weill B; Batteux F; Guilpain P
Arthritis Rheum; 2011 Jul; 63(7):2105-15. PubMed ID: 21437874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
